There were 275 press releases posted in the last 24 hours and 307,063 in the last 365 days.

Cell Isolation Market To Reach USD 18.26 Billion By 2026 | Reports And Data

Cell Isolation Market Size – USD 4.9 Billion in 2018, Market Growth - CAGR of 17.7 %, Cell Isolation Market Trends – Product launches and research for advanced cell isolation options.

/EIN News/ -- New York, Nov. 25, 2019 (GLOBE NEWSWIRE) -- In the recent years, interest of biotechnology companies and scientists in cancer and stem cell research has increased. Advanced cell isolation products deliver improved separation of biological molecules including proteins, nucleic acids, chromatin and protein complexes for further analysis. In addition to this, there has been an increase in demand for personalized medicine. This has further helped this market grow.

According to the current analysis of Reports and Data, The global cell isolation market was valued at USD 4.9 billion in 2018 and is expected to reach USD 18.28 billion by the year 2026, at a CAGR of 17.7%. Cell isolation is the process of extracting a specialized cell from a heterogeneous mixture and then process it to identify its properties and replicate it to develop new therapies. For the determination of appropriate separation technique, an exhaustive analysis of the cell size, cell behavior, density, antigen status, and hydrophobic surface properties are done.

Cell isolation plays a very vital role in the diagnostics and research of chronic diseases. It helps in drug discovery by studying the behaviour of the cells and their response to disease and drugs. This technique of drug discovery helps to generate medicines that can be used for the treatment of various diseases such as cancer, genetic disorders, and autoimmune diseases. With incidents of chronic diseases on the rise across the world, the research, drug development, and clinical trials on various cell-based therapies also need to be increased. Therefore, the demand for cell isolation market will also have a boost.

 This will be a significant factor fuelling the growth of the cell isolation market. The cell separation techniques play a vital role in personalized medicines, which are used for early detection of disease, selection of appropriate treatment, and determining the prognosis of the therapy. All these factors have contributed towards a positive dynamic growth curve of this market, and it is expected to keep growing in the coming years.

Request free sample of this research report at:

Further key findings from the report suggest:

  • Cell isolation market is growing at a CAGR of 2% in Asia-Pacific followed by North America & Europe, with 17.7% and 17.6% CAGR, respectively.
  • Currently, North America dominates the market for cell isolation, followed by Europe. It is expected that Asia-Pacific region will lead in terms of CAGR in the forecast period, owing it to the increasing awareness for this method as an effective treatment for various chronic diseases, and favorable government regulations supporting the adoption of cell isolation method.
  • The accelerating growth will provide immense growth opportunities to market participants. To make the most of these opportunities, cell isolation companies should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
  • Key players of this industry are Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, GE Healthcare, Merck KgaA, Miltenyi Biotec, pluriSelect, STEMCELL Technologies Inc., Terumo BCT and Bio-Rad Laboratories Inc. who are investing a lot in research and development to bring in innovations to carve a niche market for themselves and get an advantage over their competitors.

To identify the key trends in the industry, click on the link below:

Segments covered in the report:

For the purpose of this study, Reports and Data have segmented the cell isolation market on the basis of product, cell type, technique, application, end use and region:                     

Product (Revenue in USD Billion, 2018 - 2026)


Reagents, kits, media, and sera





Flow cytometers

Filtration systems

Magnetic-activated cell separator systems

Delivery Mode Type (Revenue, USD Million; 2016–2026)

Human cells

Differentiated Cells

Stem Cells

Animal Cells     

Technique (Revenue in USD Billion, 2018 - 2026)     

  • Centrifugation
  • Surface marker
  • Filtration

Application (Revenue in USD Billion, 2018 - 2026)     

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration & Regenerative Medicine
  • Vitro Diagnostics

End Use (Revenue in USD Billion, 2018 - 2026)     

  • Research laboratories and institutes
  • Biotechnology and biopharmaceutical companies
  • Cell banks
  • Hospitals and diagnostic laboratories

Order Now:

Regional Outlook (Revenue in USD Million; 2016–2026)

•             North America

o             U.S.

o             Canada

•             Europe

o             Germany

o             France

o             UK

o             Spain

o             Italy

o             Rest of the Europe

•             Asia Pacific

o             China

o             India

o             Japan

o             Rest of Asia-Pacific

•             Middle East & Africa

o             Latin America

•             Brazil

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson

Head of Business Development

Reports And Data | Web:

Direct Line: +1-212-710-1370


Primary Logo